Compare ATRC & VZLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATRC | VZLA |
|---|---|---|
| Founded | 2000 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.2B |
| IPO Year | 2005 | 2019 |
| Metric | ATRC | VZLA |
|---|---|---|
| Price | $29.95 | $3.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $51.17 | $7.00 |
| AVG Volume (30 Days) | 545.5K | ★ 7.8M |
| Earning Date | 04-28-2026 | 12-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.74 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $201,630,000.00 | N/A |
| Revenue This Year | $15.17 | N/A |
| Revenue Next Year | $12.42 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.40 | N/A |
| 52 Week Low | $28.32 | $1.69 |
| 52 Week High | $43.18 | $7.19 |
| Indicator | ATRC | VZLA |
|---|---|---|
| Relative Strength Index (RSI) | 42.21 | 32.26 |
| Support Level | $28.69 | $2.85 |
| Resistance Level | $32.85 | $3.48 |
| Average True Range (ATR) | 1.14 | 0.21 |
| MACD | 0.20 | -0.05 |
| Stochastic Oscillator | 37.59 | 14.34 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Vizsla Silver Corp is a junior mineral exploration and development company focused on advancing its Panuco silver-gold project located in Sinaloa, Mexico. The property contains quartz-carbonate veins with workings defining both steeply plunging and sub-horizontal ore shoots. Mineralization occurs as silver sulphides including argentite and acanthite, native gold, electrum and native silver associated with pyrite, minor galena, sphalerite and rare chalcopyrite. It has one operating segment, which is principally mineral exploration.